In this first of two podcasts, Tracey M. Piparo, PA-C and Martin C. Mahoney, MD, PhD discuss the benefits of pneumococcal vaccination, review the types of pneumococcal vaccines currently available, and provide ACIP’s recently updated age-based and risk-based recommendations on when to use the new conjugated pneumococcal vaccines. This activity is available for CE/CME credit. Claim your credit at pce.is/pneu . Contributors: Martin C. Mahoney, MD, PhD Professor Department of Epidemiology and Envir...
Feb 10, 2022•17 min•Ep. 28
In this second of two podcasts, Tracey M. Piparo, PA-C and Martin C. Mahoney, MD, PhD discuss barriers to pneumococcal vaccination, especially in the younger risk-based population, and provide specific strategies providers can implement to help improve pneumococcal vaccination coverage rates in effort to decrease the burden of pneumococcal disease. This activity is available for CE/CME credit. Claim your credit at pce.is/pneu . Contributor: Martin C. Mahoney, MD, PhD Professor Department of Epid...
Feb 10, 2022•19 min•Ep. 29
In this second of 2 podcasts, Tracey Piparo, PA-C and Martin C. Mahoney, MD, PhD provide strategies to overcome HPV vaccination barriers to improve our HPV vaccination rates among eligible individuals. The podcast includes a discussion of both provider and patient/caregiver barriers as well as specific strategies you can implement, including use of shared-decision making, to help prevent HPV-associated cancers through higher HPV vaccination rates. This activity is available for CE/CME credit. Cl...
Feb 09, 2022•20 min•Ep. 27
Tune into this informative conversation between Tracey M. Piparo, PA-C and Martin C. Mahoney, MD, PhD regarding the appropriate use of HPV vaccines for prevention of HPV-related cancers. Topics covered in this podcast include an overview of the burden of HPV, HPV vaccination coverage rates across different age groups, eligibility for HPV vaccination, and age-based dosing schedules. This activity is available for CE/CME credit. Claim your credit at pce.is/hpv . Contributors: Martin C. Mahoney, MD...
Feb 09, 2022•18 min•Ep. 26
In this second of two podcasts, hear Dr Robin Dore discuss key information from ACR Convergence 2021 , including the use of COVID-19 vaccine in immunosuppressed adults with autoimmune diseases; the cardiovascular risk of hydroxychloroquine in rheumatoid arthritis; whether the boxed warning for romosozumab helps prevent inappropriate use in postmenopausal women with osteoporosis and a history of myocardial infarction or stroke; how the incidence of cardiovascular events in patients with rheumatoi...
Dec 17, 2021•22 min•Ep. 25
In this first of two podcasts, hear Dr Vibeke Strand discuss key information from ACR Convergence 2021 , including the potential to intervene in patients who are at high risk for developing rheumatoid arthritis; whether vitamin D3 and n-3 fatty acids can prevent autoimmune disease; the Food and Drug Administration’s perspective on the safety of Janus kinase inhibitors; and results from a phase 3b/4 randomized safety study of tofacitinib vs tumor necrosis factor inhibitors. This activity is avail...
Dec 10, 2021•17 min•Ep. 24
In this second of 2 podcasts, Tish Haight, ACNP, CCRN, BC, and January-Jill Ogoy, DHSc, MPA, PA-C, provide clinical perspective on selected practice changing abstracts, covering a variety of topics from the CHEST 2021 Annual Meeting. Topics covered in this podcast include a chronic cough treatment in the pipeline, inhaled corticosteroid use and COVID-19 outcomes, and paradoxical bronchospasm with short-acting beta 2-agonists.. This activity is available for CE/CME credit. Claim your credit at pc...
Nov 22, 2021•15 min•Ep. 23
In this first of 2 podcasts, Tish Haight, ACNP, CCRN, BC, and January-Jill Ogoy, DHSc, MPA, PA-C, provide clinical perspective on selected practice changing abstracts, covering a variety of topics from the CHEST 2021 Annual Meeting. Topics covered in this podcast include a comparison of idiopathic pulmonary arterial hypertension outcomes, an evaluation of combination therapies for the treatment of COPD, and the use of CPAP in patients hospitalized with COVID-19 pneumonitis. This activity is avai...
Nov 22, 2021•17 min•Ep. 22
In this podcast, an expert offers his perspective on the role of newer agents in atopic dermatitis—when they’re indicated, how to use them, where they fit on the therapeutic ladder, and adverse effects to monitor for. Also, tips on how to individualize therapy and anticipate adherence issues. The podcast concludes with thoughts on how to address some frequently-asked questions from patients and caregivers. This activity is available for CE/CME credit. Claim your credit at pce.is/AD. Contributors...
Nov 16, 2021•31 min•Ep. 21
Targeted therapies address the underlying pathways that cause airflow obstruction in patients with asthma, including a number of biologic therapies that have been approved. Omalizumab targets IgE (approved for moderate to severe persistent asthma). Three agents target IL-5, which plays a key role in the activation of eosinophils, and are approved for severe eosinophilic asthma: mepolizumab, reslizumab, and benralizumab. Dupilumab targets IL-4/13 and has been approved for moderate to severe eosin...
Oct 29, 2021•26 min•Ep. 20
Asthma is now recognized as a heterogeneous, multidimensional disease that involves numerous pathophysiologic factors, including bronchiolar inflammation with airway constriction and resistance. The identification of distinct patient populations (phenotypes/endotypes) is increasingly being recognized as an important strategy for optimizing the management of patients with asthma. Asthma phenotype is based on clinical symptoms such as respiratory function, onset age, and blood biochemical examinat...
Oct 29, 2021•25 min•Ep. 19
An early, accurate diagnosis and appropriate pharmacologic and nonpharmacologic treatment of IPF are imperative for improved outcomes. Given the poor prognosis of IPF, educating and involving patients in their care is necessary for optimal quality of life. In this podcast, Corinne R. Young, MSN, FNP-C, FCCP, provides an overview of key points addressed by expert faculty during a live webinar. Please visit PCE.IS/ipf to view more activities on IPF. Corinne R. Young, MSN, FNP-C, FCCP Founder and P...
Oct 13, 2021•21 min•Ep. 18
Effective influenza management during the COVID-19 pandemic requires a knowledge of emerging diagnostics, immunizations, and antiviral agents. The armamentarium for influenza treatment now includes multiple classes including neuraminidase inhibitors (eg, oseltamivir) and the polymerase acidic endonuclease inhibitor, baloxavir. In this podcast, Mary Knudtson, DNSc, NP, FAAN, asks questions from healthcare professionals to infectious disease expert, Michael G. Ison, MD, MS on timely, individualize...
Aug 19, 2021•15 min•Ep. 17
Influenza management continues to increase in complexity as new diagnostic, prevention, and treatment options emerge and the COVID-19 pandemic adds additional considerations. Antiviral therapies for influenza now include neuraminidase inhibitors (eg, oseltamivir) and baloxavir. In this podcast, Lawrence Herman, DMSc, MPA, PA-C, asks timely influenza questions from healthcare professionals to infectious disease expert, Tracy Zivin-Tutela, MD. This activity is available for CE/CME credit. Claim yo...
Aug 19, 2021•15 min•Ep. 16
In the global effort to address the COVID-19 pandemic, healthcare practitioners need to stay up to date as the Emergency Use Authorization (EUAs) for treatments and vaccines change rapidly. This 6-part podcast series opens with a discussion of how EUAs work and how they are different from full approval. In the subsequent episodes, experts explain the latest evidence-based information on inpatient and outpatient antiviral treatments, the most recent information on available vaccines, and how the ...
Apr 30, 2021•15 min•Ep. 15
In the global effort to address the COVID-19 pandemic, healthcare practitioners need to stay up to date as the Emergency Use Authorization (EUAs) for treatments and vaccines change rapidly. This 6-part podcast series opens with a discussion of how EUAs work and how they are different from full approval. In the subsequent episodes, experts explain the latest evidence-based information on inpatient and outpatient antiviral treatments, the most recent information on available vaccines, and how the ...
Apr 30, 2021•21 min•Ep. 14
In the global effort to address the COVID-19 pandemic, healthcare practitioners need to stay up to date as the Emergency Use Authorization (EUAs) for treatments and vaccines change rapidly. This 6-part podcast series opens with a discussion of how EUAs work and how they are different from full approval. In the subsequent episodes, experts explain the latest evidence-based information on inpatient and outpatient antiviral treatments, the most recent information on available vaccines, and how the ...
Apr 30, 2021•16 min•Ep. 13
In the global effort to address the COVID-19 pandemic, healthcare practitioners need to stay up to date as the Emergency Use Authorization (EUAs) for treatments and vaccines change rapidly. This 6-part podcast series opens with a discussion of how EUAs work and how they are different from full approval. In the subsequent episodes, experts explain the latest evidence-based information on inpatient and outpatient antiviral treatments, the most recent information on available vaccines, and how the ...
Apr 30, 2021•21 min•Ep. 12
In the global effort to address the COVID-19 pandemic, healthcare practitioners need to stay up to date as the Emergency Use Authorization (EUAs) for treatments and vaccines change rapidly. This 6-part podcast series opens with a discussion of how EUAs work and how they are different from full approval. In the subsequent episodes, experts explain the latest evidence-based information on inpatient and outpatient antiviral treatments, the most recent information on available vaccines, and how the ...
Apr 30, 2021•22 min•Ep. 11
In the global effort to address the COVID-19 pandemic, healthcare practitioners need to stay up to date as the Emergency Use Authorization (EUAs) for treatments and vaccines change rapidly. This 6-part podcast series opens with a discussion of how EUAs work and how they are different from full approval. In the subsequent episodes, experts explain the latest evidence-based information on inpatient and outpatient antiviral treatments, the most recent information on available vaccines, and how the ...
Apr 30, 2021•13 min•Ep. 10
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are now firmly established as guideline-recommended antiglycemic agents of choice in patients with type 2 diabetes, especially when comorbid disease is evident or when the patient is at high risk for such conditions. Join Davida Kruger, NP and Anne Peters, MD for a lively discussion on the use of GLP-1 RAs in clinical practice, including how to use shared decision-making to choose an ideal agent based on patient, disease, and GLP-1 RA charact...
Mar 26, 2021•15 min•Ep. 8
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are now firmly established as guideline-recommended antiglycemic agents of choice in patients with type 2 diabetes, especially when comorbid disease is evident or when the patient is at high risk for such conditions. In this second of two podcasts, Davida Kruger, NP and Anne Peters, MD share tips and pearls for treating patients with type 2 diabetes using GLP-1 RAs, including when to choose a GLP-1 RA, how to broach the topic of a first injec...
Mar 26, 2021•18 min•Ep. 9
A number of specific therapies are now available for pulmonary arterial hypertension (PAH), and the outlook for patients with PAH has never been better. But first PAH must be differentiated from the other forms of pulmonary hypertension. In this podcast, Corinne Young, FNP-C, president of the Association of Pulmonary Advanced Practice Providers, talks with pulmonary hypertension expert Martha Kingman, FNP-C, DNP, about establishing the diagnosis of PAH, determining the subcategory of PAH, today’...
Feb 15, 2021•34 min•Ep. 7
All pulmonary hypertension is not the same, and it’s important to differentiate among the five different subtypes to ensure effective management. In this podcast, Corinne Young, FNP-C, president of the Association of Pulmonary Advanced Practice Providers, talks with pulmonary hypertension expert Martha Kingman, FNP-C, DNP, about the classification system for pulmonary hypertension, how to distinguish the five subtypes clinically, and best practices in management. This episode is available for CE...
Feb 15, 2021•30 min•Ep. 6
In this episode, Karl Doghramji, MD, Medical Director at the Jefferson Sleep Disorders Center in Philadelphia, talks to clinicians about the newest class of pharmacologic agents, orexin receptor antagonists, for the treatment of insomnia. He also discusses how to recognize signs, symptoms, and risk factors that should trigger screening, differentiation of the different types of sleep disorders, and lifestyle measures that should be part of any treatment.
Nov 03, 2020•24 min•Ep. 5
In this episode, Diana Atashroo, MD, a specialist in endometriosis treatment, gives expert advice on how to recognize and treat endometriosis early, before it transitions to daily, chronic pain and a centralized pain state. She also provides recommendations for long-term management and coordination of care.
Oct 27, 2020•31 min•Ep. 4
Primary care practitioners play a major role in the management of asthma, providing diagnosis, patient education, and management plans. But when the asthma remains uncontrolled, management can be challenging. On this podcast, Corinne Young FNP-C, president of the Association of Pulmonary Advanced Practice Providers speaks with asthma expert Ann Hefel, FNP-C of Children's Hospital Colorado about what clinicians have in their therapeutic toolbox to help patients with moderate to severe disease who...
Oct 19, 2020•26 min•Ep. 3
As many as 20% of patients with asthma may not be achieving adequate control of their symptoms, even after they have maximized inhaled corticosteroids and their long-acting beta 2 agonist. If left uncontrolled, patients are at increased risk for serious exacerbations that can lead to ED visits and extended hospitalizations. In this podcast, Corinne Young, FNP-C, president of the Association of Pulmonary Advanced Practice Providers, talks with her colleague Ann Hefel, FNP, an allergy and asthma s...
Oct 19, 2020•24 min•Ep. 2
In this episode, Dr. Brooks Cash provides an expert look at chronic idiopathic constipation, how to differentiate it from a commonly confused condition, irritable bowel syndrome, and when diagnosed what treatment options are available, both nonpharmacologic and pharmacologic.
Oct 01, 2020•26 min•Ep. 1
